NUVASIVE, INC. (NASDAQ:NUVA) Files An 8-K Other Events
Item 8.01 Other Events.
On June 1, 2017, NuVasive, Inc. issued a press release announcing
the appointment of Skip Kiil as Executive Vice President,
International. A copy of this press release is furnished as
Exhibit 99.1 hereto.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit Number |
Description |
|
99.1 |
Press release issued by NuVasive, Inc. on June 1, 2017 |
About NUVASIVE, INC. (NASDAQ:NUVA)
Nuvasive, Inc. is a medical device company in the spine market. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The Company offers two product lines: spine surgery products and biologics. The Company’s spine surgery products line offerings include thoracolumbar product offerings, cervical product offerings, Intra-Operative Monitoring (IOM) services and disposables, which are used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The Company’s biologics product line offerings includes allograft (donated human tissue), FormaGraft (a collagen synthetic product), Osteocel Plus and Osteocel Pro (each an allograft cellular matrix containing viable mesenchymal stem cells (MSCs)), and AttraX (a synthetic bone graft material), all of which are used to aid the spinal fusion or bone healing process. NUVASIVE, INC. (NASDAQ:NUVA) Recent Trading Information
NUVASIVE, INC. (NASDAQ:NUVA) closed its last trading session down -0.33 at 75.03 with 654,107 shares trading hands.
